Pulse Biosciences Inc (DE) (PLSE)
$52.00
$1.67
(3.31%)
As on 01-Sep-2026 13:37EDT
Market cap
$3,393 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
34.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.8 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-1.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.2
-
Face value
--
-
Shares outstanding
71,322,607
10 Years Aggregate
CFO
$-250.22 Mln
EBITDA
$-332.15 Mln
Net Profit
$-335.96 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pulse Biosciences Inc (DE) (PLSE)
| 278.7 | 48.0 | 108.0 | 234.6 | 122.7 | 15.0 | 26.6 |
|
BSE Sensex
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Pulse Biosciences Inc (DE) (PLSE)
| -21.1 | 41.8 | 341.9 | -81.3 | -37.9 | 77.9 | 17.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pulse Biosciences Inc (DE) (PLSE)
|
52.0 | 3,392.8 | 1.2 | -80.1 | -4,723.0 | -88.9 | -- | 34.9 |
| 61.3 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.4 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 56.1 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 176.1 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.9 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 90.5 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 322.7 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 169.6 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout Pulse Biosciences Inc (DE) (PLSE)
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft... tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida. Read more
-
Executive Chairman
Mr. Robert W. Duggan
-
Executive Chairman
Mr. Robert W. Duggan
-
Headquarters
Miami, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Pulse Biosciences Inc (DE) (PLSE)
What is the current share price of Pulse Biosciences Inc (DE) (PLSE) Today?
The share price of Pulse Biosciences Inc (DE) (PLSE) is $52.00 (NASDAQ) as of 01-Sep-2026 13:37 EDT. Pulse Biosciences Inc (DE) (PLSE) has given a return of 122.66% in the last 3 years.
What is the current PB & PE ratio of Pulse Biosciences Inc (DE) (PLSE)?
Since, TTM earnings of Pulse Biosciences Inc (DE) (PLSE) is negative, P/E ratio is not available.
The P/B ratio of Pulse Biosciences Inc (DE) (PLSE) is 34.85 times as on 28-Aug-2026, a 820 premium to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-12.71 |
11.47 |
2024 |
-18.97 |
8.85 |
2023 |
-15.97 |
15.19 |
2022 |
-1.75 |
-45.87 |
2021 |
-6.95 |
12.30 |
What is the 52 Week High and Low of Pulse Biosciences Inc (DE) (PLSE)?
The 52-week high and low of Pulse Biosciences Inc (DE) (PLSE) are Rs 52.00 and Rs 12.56 as of 02-Sep-2026.
What is the market cap of Pulse Biosciences Inc (DE) (PLSE)?
Pulse Biosciences Inc (DE) (PLSE) has a market capitalisation of $ 3,393 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Pulse Biosciences Inc (DE) (PLSE)?
Before investing in Pulse Biosciences Inc (DE) (PLSE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.